SAN DIEGO--(BUSINESS WIRE)--Digital health startup CARI Health was awarded an SBIR Fast Track grant from the National Institute on Drug Abuse (NIDA), an agency of the National Institutes of Health (NIH), to help it bring the world’s first wearable medication monitor to market. CARI Health is eligible for up to $2.8M over three years as project milestones are successfully completed within Phase I and Phase II portions of the grant.

圣地亚哥-（商业线）-数字健康创业公司CARI health获得了美国国立卫生研究院（NIH）机构国家药物滥用研究所（NIDA）的SBIR快速通道资助，帮助它将世界上第一个可穿戴式药物监护仪推向市场。由于项目里程碑在赠款的第一阶段和第二阶段成功完成，CARI Health在三年内有资格获得280万美元的资金。

The award funding will go toward supporting product development and conducting human clinical studies for CARI Health’s wearable remote medication monitoring device..

获奖资金将用于支持CARI Health可穿戴远程药物监测设备的产品开发和人体临床研究。。

Over the past several years, CARI Health has received funding from the San Diego Angel Conference (SDAC), NuFund Venture Group, Cove Fund, Chemical Angel Fund, Device of Tomorrow Capital, and several individual angel investors. More recently, it received investments from the Cedars Sinai Accelerator and the Rady Venture Fund (UCSD)..

在过去几年中，CARI Health已获得San Diego Angel Conference（SDAC），NuFund Venture Group，Cove Fund，Chemical Angel Fund，明天资本设备以及几个单独的Angel投资者的资助。最近，它收到了Cedars-Sinai加速器和Rady Venture Fund（UCSD）的投资。。

“As the national opioid crisis continues to escalate amid growing illicit fentanyl use, the discovery of new and innovative solutions is urgent,” says CARI Health Founder and CEO Patrik Schmidle. “Wearable remote monitoring is a convenient and patient-friendly way to demonstrate methadone treatment compliance remotely.

CARI Health创始人兼首席执行官Patrik Schmidle说：“随着越来越多的非法芬太尼使用，国家阿片类药物危机继续升级，发现新的创新解决方案势在必行。“可穿戴远程监控是一种方便且耐心的方式，可以远程演示美沙酮治疗依从性。

Under today’s standard of care, especially in the beginning of methadone treatment, patients have to show up almost daily for clinic visits, which creates a significant barrier to begin and remain in treatment.”.

根据今天的护理标准，特别是在美沙酮治疗开始时，患者必须几乎每天出现在诊所就诊，这对开始和继续治疗造成了重大障碍。

Schmidle originally launched CARI Health after a close family member struggled with opioid use disorder.

Schmidle最初在一位亲密的家庭成员与阿片类药物使用障碍作斗争后推出了CARI Health。

By participating in programs like the Institute for the Global Entrepreneur MedTech Accelerator at University of California San Diego, MedTech Innovator, the world’s largest MedTech accelerator, and the Cedars Sinai Accelerator, CARI Health has benefitted from best-in-class mentorship and expert guidance.

通过参与加州大学圣地亚哥分校全球企业家MedTech加速器研究所，MedTech Innovator，世界上最大的MedTech加速器和Cedars-Sinai加速器等项目，CARI Health受益于一流的指导和专家指导。

It was also selected as one of Connect San Diego’s 2022 Cool Companies and was honored again in 2023. In addition, CARI is part of San Diego-based EvoNexus, which has an average 2% admittance rate..

它也被选为Connect圣地亚哥2022家酷公司之一，并于2023年再次获得荣幸。此外，CARI是基于圣地亚哥的EvoNexus的一部分，平均准入率为2%。。

“This NIDA grant will support CARI Health’s product development as we build on the success of our efforts to date,” said Schmidle. “And once our product is ready to be deployed in human studies, the funds will help us conduct those human trials.”

施密德说：“这项NIDA拨款将支持CARI Health的产品开发，因为我们以迄今为止的努力取得成功为基础。“一旦我们的产品准备好用于人体研究，这些资金将帮助我们进行这些人体试验。”

Research reported in this press release was supported by the National Institute on Drug Abuse of the National Institutes of Health under award number R44DA059523-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health..

本新闻稿中报道的研究得到了美国国立卫生研究院国家药物滥用研究所的支持，奖项编号为R44DA059523-01。内容完全是作者的责任，不一定代表国立卫生研究院的官方观点。。

About CARI Health

关于CARI Health

CARI Health is focused on the future of wearable remote medication monitoring, enabling clinicians to view patient medication levels in real time, and keep them on life-saving medications. www.CARIHealth.com, LinkedIn.

CARI Health专注于可穿戴远程药物监控的未来，使临床医生能够实时查看患者的药物水平，并将其保留在挽救生命的药物上。www.CARIHealth.com，LinkedIn。